SMSPHARMABSESMS Pharmaceuticals LtdHighNeutral
Announced Thu, 3 Jul · 09:03 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd

Ownership Changes View source PDF

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

BSE has received a disclosure under Regulation 29(2) of SEBI's Substantial Acquisition of Shares & Takeovers Regulations, 2011, filed by Vistra ITCL (India) Ltd, which acts as a trustee/ custodian for shares of SMS Pharmaceuticals. Regulation 29(2) disclosures typically relate to encumbrance (pledge) of shares held by promoters or promoter group entities. The available filing does not specify whether this is a creation, invocation, or release of pledge, nor the quantum of shares involved.

Likely market impact

The headline alone is not enough to determine any meaningful impact on shareholders. Investors should check the detailed disclosure for the nature and size of the encumbrance change before drawing any conclusions.